Astera Labs (NASDAQ:ALAB) Stock Price Down 5.3% Following Insider Selling

Astera Labs, Inc. (NASDAQ:ALAB)’s share price traded down 5.3% during trading on Monday after an insider sold shares in the company. The company traded as low as $320.23 and last traded at $324.11. 3,480,070 shares changed hands during trading, a decline of 33% from the average daily volume of 5,182,813 shares. The stock had previously closed at $342.21.

Specifically, Director Stefan Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction that occurred on Wednesday, October 7th. The stock was sold at an average price of $376.06, for a total transaction of $3,382,283.64. Following the sale, the director owned 2,648 shares of the company’s stock, valued at approximately $995,806.88. This trade represents a 77.25% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan Dyckerhoff sold 3,505 shares of the business’s stock in a transaction that occurred on Wednesday, October 7th. The shares were sold at an average price of $376.06, for a total value of $1,318,090.30. Following the sale, the director owned 47,019 shares in the company, valued at approximately $17,681,965.14. This represents a 6.94% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Analysts Set New Price Targets

ALAB has been the subject of a number of recent research reports. Susquehanna upped their target price on Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research note on Friday, July 31st. Royal Bank Of Canada lifted their price target on shares of Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Morgan Stanley boosted their price target on shares of Astera Labs to $335.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. Citigroup cut shares of Astera Labs from a “buy” rating to a “hold” rating in a research note on Friday. Finally, Northland Securities cut shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Friday. Eleven analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $348.33.

Astera Labs Stock Down 5.3%

The company has a market capitalization of $56.23 billion, a price-to-earnings ratio of 160.45 and a beta of 3.68. The business has a fifty day simple moving average of $317.44 and a two-hundred day simple moving average of $291.57.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The business had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. Astera Labs’s quarterly revenue was up 104.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities analysts predict that Astera Labs, Inc. will post 2.70 earnings per share for the current fiscal year.

Institutional Trading of Astera Labs

Large investors have recently bought and sold shares of the stock. BlackRock Inc. acquired a new stake in shares of Astera Labs in the 2nd quarter valued at $6,609,581,000. ABS Investment Management LLC bought a new stake in shares of Astera Labs in the 2nd quarter worth about $1,980,382,000. Van ECK Associates Corp grew its holdings in shares of Astera Labs by 20.0% in the 2nd quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company’s stock worth $1,080,980,000 after purchasing an additional 373,545 shares during the last quarter. Bank of America Corp DE acquired a new stake in shares of Astera Labs during the 2nd quarter worth about $1,061,791,000. Finally, Atreides Management LP acquired a new stake in shares of Astera Labs during the 2nd quarter worth about $587,736,000. 60.47% of the stock is currently owned by institutional investors.

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.